Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor

K. C. Choi, S. Park, B. J. Lim, A. R. Seong, Y. H. Lee, masaki shiota, Akira Yokomizo, S. Naito, Y. Na, H. G. Yoon

Research output: Contribution to journalComment/debate

4 Citations (Scopus)
Original languageEnglish
Number of pages1
JournalBiochemical Journal
Volume433
Issue number3
Publication statusPublished - Feb 1 2011

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor. / Choi, K. C.; Park, S.; Lim, B. J.; Seong, A. R.; Lee, Y. H.; shiota, masaki; Yokomizo, Akira; Naito, S.; Na, Y.; Yoon, H. G.

In: Biochemical Journal, Vol. 433, No. 3, 01.02.2011.

Research output: Contribution to journalComment/debate

Choi, K. C. ; Park, S. ; Lim, B. J. ; Seong, A. R. ; Lee, Y. H. ; shiota, masaki ; Yokomizo, Akira ; Naito, S. ; Na, Y. ; Yoon, H. G. / Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor. In: Biochemical Journal. 2011 ; Vol. 433, No. 3.
@article{4d38934338b44505ab2b79882cc4475d,
title = "Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor",
author = "Choi, {K. C.} and S. Park and Lim, {B. J.} and Seong, {A. R.} and Lee, {Y. H.} and masaki shiota and Akira Yokomizo and S. Naito and Y. Na and Yoon, {H. G.}",
year = "2011",
month = "2",
day = "1",
language = "English",
volume = "433",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor

AU - Choi, K. C.

AU - Park, S.

AU - Lim, B. J.

AU - Seong, A. R.

AU - Lee, Y. H.

AU - shiota, masaki

AU - Yokomizo, Akira

AU - Naito, S.

AU - Na, Y.

AU - Yoon, H. G.

PY - 2011/2/1

Y1 - 2011/2/1

UR - http://www.scopus.com/inward/record.url?scp=78751501339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751501339&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:78751501339

VL - 433

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -